Aptinyx Inc reported $-21106000 in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -14.32M 28.46M
Adamas Pharmaceuticals ADMS:US -5502000 3.51M
Biogen BIIB:US $ 991.8M 155.8M
Daiichi Sankyo 4568:JP Y 53261M 7192M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Gw Pharmaceuticals GWPH:US $ -17.18M 2.02M
Halozyme Therapeutics HALO:US $ 76.34M 17.51M
Intra Cellular Therapies ITCI:US $ -77.19M 8.17M
Marinus Pharmaceuticals MRNS:US $ -19.08M 4.32M
Neurocrine Biosciences NBIX:US $ 47.3M 23.1M
Novartis NOVN:VX SF 4837M 65M
Ultragenyx Pharmaceutical RARE:US $ -86.61M 6.96M
Vertex Pharmaceuticals VRTX:US $ 1087.41M 1092.53M